Record:   Prev Next
書名 Resistance to tyrosine kinase inhibitors / edited by Daniele Focosi
出版項 Cham : Springer International Publishing : Imprint: Springer, 2016
國際標準書號 9783319460918 (electronic bk.)
9783319460901 (paper)
國際標準號碼 10.1007/978-3-319-46091-8 doi
book jacket
說明 1 online resource (xiii, 188 pages) : illustrations, digital ; 24 cm
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
text file PDF rda
系列 Resistance to targeted anti-cancer therapeutics, 2196-5501 ; volume 10
Resistance to targeted anti-cancer therapeutics ; volume 10
附註 Tyrosine Kinase Signaling Pathways in Normal and Cancer Cells -- Resistance to Tyrosine Kinase Inhibitors in different types of solid cancer -- The Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: An Overview -- Resistance to FLT3 Inhibitors -- Resistance to ALK inhibitors -- Resistance to Angiokinase Inhibitors -- Indications for Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors
The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will first introduce the common denominators of small-molecule and antibody-derived inhibitors, as well as the general phenomenon of resistance. The volume will then detail resistance to the most commonly used classes of tyrosine kinase inhibitors, and will focus specific chapters on resistance to BCR-ABL1, FLT3, angiokinase family members, and ALK inhibitors
Host Item Springer eBooks
主題 Protein-tyrosine kinase -- Inhibitors
Drug resistance
Biomedicine
Cancer Research
Alt Author Focosi, Daniele, editor
SpringerLink (Online service)
Record:   Prev Next